PHARMAVIE A/S: Financial statements 2012
CVR: 26553148
Source: annual report 2012, Danish Business Authority
01/10/2011 – 30/09/2012
PHARMAVIE A/S (CVR 26553148) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 1,565,601 and a net result of DKK 434,593. Equity in the 2012 report amounted to DKK 8,243,109. The solvency ratio was 48.1%.
- Gross Profit
- DKK 1,565,601
- Profit/Loss
- DKK 434,593
- Equity
- DKK 8,243,109
- Total Assets
- DKK 17,131,103
Official annual report
Keep an eye on PHARMAVIE A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of February 12, 2012, Kren Erik Whittard Nielsen has left the board of directors of PHARMAVIE A/S.
About PHARMAVIE A/S
PHARMAVIE A/S is a Danish company of the type Aktieselskab based in Greve, founded in 2002. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named PHARMAVIE CONSULT A/S. The management consists of Carsten Wærn. The board consists of Margit Wærn (chair), Carsten Wærn and Vibeke Wærn. The company is owned by MAW HOLDING ApS and VIPS HOLDING ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 172,767 and a net result of DKK 821,439 compared with DKK 1,603,686 the year before. Equity in the 2025 report amounted to DKK -978,681.